Physicians Don’t Always Understand the FDA Approval Process, Survey Finds
Many physicians have only a hazy understanding of the FDA's approval process for new drugs and medical devices, a national survey found....
Many physicians have only a hazy understanding of the FDA's approval process for new drugs and medical devices, a national survey found....
In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief....
Last fall, the World Health Organization and some national drug regulators urged influenza vaccine manufacturers to drop the component known as B/Yamagata from flu vaccines as quickly as possible, citing the fact that this lineage of flu B viruses appears to have been snuffed out...
Breast cancer screening and new treatments were associated with a large reduction in mortality from the disease over the past 45 years, according to results from a simulation model-based study....
As new treatments reach the market, a problem appears: real-world research shows dissatisfying outcomes and access disparities. One US study reveals that within the early years of a novel interventional device usage, women fare significantly worse than men, even after accounting for underlying differences....
Generative AI’s earliest applications in medicine have largely focused on curing not patients, but the plague of productivity physicians lose to digital documentation. Now, research suggests a way that large language models like ChatGPT could benefit both patients and providers: by automatically extracting a patient’s...
A growing study in Wisconsin is focused on understanding Alzheimer’s disease and its impact on the African American community. ...
Deming, ACI/Schwenn Family associate professor in the Division of Hematology, Medical Oncology and Palliative Care at UW School of Medicine and Public Health, did not plan to treat patients when he started medical school — much of his experience had been in laboratory medicine, and...
Topics highlighted include diversity and inclusion, decentralized clinical trial (DCT) elements, workforce challenges, and a possible role for sponsors and contract research organizations (CROs) in supporting outreach by sites based in diverse communities....
The five-year study will provide state-of-the-art imaging and blood-based biomarkers for researchers around the world to study and advance the field of Alzheimer’s and related dementias. The work is also designed to shed light on mixed dementia, where more than one neurological disease is contributing...